M. Delgado-Ureña

Circulating tumor cells criteria (CyCAR) versus standard RECIST criteria for treatment response assessment in metastatic colorectal cancer patients

J. Lorente, Hugh Ilyine, F. G. Ortega, 2018, Journal of Translational Medicine.

A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study

M. Pirmohamed, A. Cambon-Thomsen, Yitian Zhou, 2023, The Lancet.

Circulating tumor cells criteria (CyCAR) versus standard RECIST criteria for treatment response assessment in metastatic colorectal cancer patients

J. Lorente, Hugh Ilyine, F. G. Ortega, 2018, Journal of Translational Medicine.